Show simple item record

dc.contributor.authorLee, Cindyen_GB
dc.contributor.authorGuinn, Barbara-Annen_GB
dc.contributor.authorBrooks, Suzanne E.en_GB
dc.contributor.authorRichardson, Deborahen_GB
dc.contributor.authorOrchard, Kim H.en_GB
dc.date.accessioned2012-05-18T08:52:25Z
dc.date.available2012-05-18T08:52:25Z
dc.date.issued2010-06
dc.identifier.citationLee, C., Guinn, B.A., Brooks, S.E., Orchard, K. (2010) 'CD66a (CEACAM1) is the only CD66 variant expressed on the surface of plasma cells in multiple myeloma: a refined target for radiotherapy trials?' 149 (5):795-6en_GB
dc.identifier.issn1365-2141
dc.identifier.pmid20230402
dc.identifier.doi10.1111/j.1365-2141.2010.08100.x
dc.identifier.urihttp://hdl.handle.net/10547/224525
dc.description.sponsorshipLeukaemia and Lymphoma Research, Cancer Research U.K.en_GB
dc.language.isoenen
dc.publisherWileyen_GB
dc.relation.urlhttp://onlinelibrary.wiley.com/doi/10.1111/j.1365-2141.2010.08100.x/abstracten_GB
dc.subjectCD66en_GB
dc.subjecttargetted radiotherapyen_GB
dc.subjectmultiple myelomaen_GB
dc.subject.meshAged
dc.subject.meshAged, 80 and over
dc.subject.meshAntigens, CD
dc.subject.meshAntigens, Neoplasm
dc.subject.meshCell Adhesion Molecules
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshMultiple Myeloma
dc.subject.meshPlasma Cells
dc.subject.meshRadioimmunotherapy
dc.titleCD66a (CEACAM1) is the only CD66 variant expressed on the surface of plasma cells in multiple myeloma: a refined target for radiotherapy trials?en
dc.typeArticleen
dc.identifier.journalBritish journal of haematologyen_GB


This item appears in the following Collection(s)

Show simple item record